pyrazines has been researched along with bradykinin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barer, GR; Cai, YN; Emery, CJ; Russell, PC | 1 |
Benos, DJ; Sapirstein, VS | 1 |
Fulton, D; Kaminski, P; McGiff, JC; Quilley, J; Wolin, MS | 1 |
Kichko, TI; Reeh, PW | 1 |
Drouet, C; Graffin, B; Hosotte, M; Kanny, G; Landy, C; Millot, I; Nadaud, J; Plancade, D; Ragot, C | 1 |
Billings, FT; Brown, NJ; Devin, JK; Nian, H; Pretorius, M; Yu, C | 1 |
Beaudouin, E; Defendi, F; Drouet, C; Moneret-Vautrin, DA; Picaud, J; Ponard, D | 1 |
1 trial(s) available for pyrazines and bradykinin
Article | Year |
---|---|
Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Cross-Over Studies; Dipeptidyl Peptidase 4; Double-Blind Method; Enalaprilat; Enzyme Inhibitors; Female; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Peptidyl-Dipeptidase A; Pyrazines; Sitagliptin Phosphate; Substance P; Sympathetic Nervous System; Triazoles; Vascular Resistance | 2014 |
6 other study(ies) available for pyrazines and bradykinin
Article | Year |
---|---|
Reactivity and site of vasomotion in pulmonary vessels of chronically hypoxic rats: relation to structural changes.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Almitrine; Angiotensin I; Animals; Bradykinin; Chronic Disease; Hypoxia; Male; Platelet Activating Factor; Pulmonary Circulation; Pyrazines; Rats; Rats, Inbred Strains; Reference Values; Respiration; Vasoconstriction; Vasodilator Agents; Vasomotor System | 1989 |
Activation of amiloride-sensitive sodium transport in C6 glioma cells.
Topics: Amiloride; Animals; Biological Transport, Active; Bradykinin; Bucladesine; Cell Line; Colchicine; Diglycerides; Epidermal Growth Factor; Glioma; Protons; Pyrazines; Rats; Sodium; Tetradecanoylphorbol Acetate | 1984 |
Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat.
Topics: Animals; Arachidonic Acid; Benzimidazoles; Benzopyrans; Bradykinin; Cromakalim; Cyclic N-Oxides; Cytochrome P-450 Enzyme System; Free Radical Scavengers; Heart; Hydrogen Peroxide; Imidazoles; In Vitro Techniques; Indomethacin; Kidney Cortex; Luminescent Measurements; Male; Microsomes; Nitric Oxide; Nitroarginine; Parasympatholytics; Perfusion; Pyrazines; Pyrroles; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Vasodilator Agents | 1997 |
TRPV1 controls acid- and heat-induced calcitonin gene-related peptide release and sensitization by bradykinin in the isolated mouse trachea.
Topics: Amiloride; Animals; Boron Compounds; Bradykinin; Calcitonin Gene-Related Peptide; Calcium; Extracellular Space; Hot Temperature; Hydrogen-Ion Concentration; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurons; Protons; Pyrazines; Pyridines; Ruthenium Red; Sensory System Agents; Sodium Channel Blockers; Trachea; TRPV Cation Channels | 2009 |
Treatment of a life-threatening laryngeal bradykinin angio-oedema precipitated by dipeptidylpeptidase-4 inhibitor and angiotensin-I converting enzyme inhibitor with prothrombin complex concentrates.
Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation Factors; Bradykinin; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypertension; Laryngeal Diseases; Male; Perindopril; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Iatrogenic angioedema associated with ACEi, sitagliptin, and deficiency of 3 enzymes catabolizing bradykinin.
Topics: Amino Acid Metabolism, Inborn Errors; Aminopeptidases; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Dipeptidyl-Peptidase IV Inhibitors; Down-Regulation; Drug Interactions; Humans; Iatrogenic Disease; Lisinopril; Lysine Carboxypeptidase; Male; Middle Aged; Peptidyl-Dipeptidase A; Polypharmacy; Pyrazines; Risk Factors; Sitagliptin Phosphate; Time Factors; Triazoles | 2014 |